Synthetic Design Lab
Latest round
- Seed
Last raised
- Jan 2024
Total raised
- $10M
Investors
- 2
About Synthetic Design Lab
Synthetic Design Lab develops innovative therapeutic solutions specializing in enhanced antibody-drug conjugates (ADCs).Synthetic Design Lab specializes in the development of its proprietary SYNTHBODY therapeutic platform, engineered to enhance the targeted delivery of antibody-drug conjugates (ADCs) by delivering payloads at least ten times more effectively than existing ADCs. This innovative technology optimizes the precision of drug delivery to specific cells, addressing various cancer indications. The company focuses on integrating biological and biophysical principles into the engineering of ADCs, thereby setting a new standard for their design and application. The primary end-users of SYNTHBODY include cancer patients and healthcare professionals in oncology, with the company aiming to bring its first therapies into clinical trials to validate the efficacy and safety of its products.Synthetic Design Lab generates revenue through partnerships and collaborations within the biotechnology sector, particularly focused on research and clinical development. The company structures its transactions primarily through B2B arrangements, including partnerships with pharmaceutical firms and research organizations that utilize their SYNTHBODY platform in drug development initiatives. Revenue is generated as these partners engage in joint ventures to develop and commercialize novel ADC therapies, leveraging the proprietary capabilities of SYNTHBODY. This model allows for shared investment in clinical trials and product development, ensuring that both parties benefit from the successful advancement of therapeutic candidates. The company is actively designing new products within the SYNTHBODY platform to advance cancer treatment options and plans to expand its reach into new markets, specifically targeting Europe and Asia by 2026.
Who invested in Synthetic Design Lab
2 investors across 1 round
See all investors in Synthetic Design Lab
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 5, 2024
Amount
$10M
Investors
Questions about Synthetic Design Lab
Who invested in Synthetic Design Lab?
Synthetic Design Lab has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synthetic Design Lab raised?
Synthetic Design Lab has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Synthetic Design Lab last raise money?
Synthetic Design Lab's most recent round on record is a Seed, in Jan 2024.
What does Synthetic Design Lab do?
Synthetic Design Lab develops innovative therapeutic solutions specializing in enhanced antibody-drug conjugates (ADCs).
Where is Synthetic Design Lab headquartered?
Synthetic Design Lab is headquartered in San Francisco, US.
Which VCs invest in companies like Synthetic Design Lab?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Synthetic Design Lab's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Synthetic Design Lab? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.